Cellular prion protein neuroprotective function: implications in prion diseases (original) (raw)
References
Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417–428 CASPubMed Google Scholar
Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122:1–5 CASPubMed Google Scholar
Moudjou M, Frobert Y, Grassi J, La Bonnardiere C (2001) Cellular prion protein status in sheep: tissue-specific biochemical signatures. J Gen Virol 82:2017–2024 CASPubMed Google Scholar
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144 CASPubMed Google Scholar
Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347 ArticleCASPubMed Google Scholar
Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90:10608–10612 CASPubMed Google Scholar
Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C (1994) No propagation of prions in mice devoid of PrP. Cell 77:967–968 CASPubMed Google Scholar
Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43–60 CASPubMed Google Scholar
Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121–127 CASPubMed Google Scholar
Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, Erpel SP, Nakaoke R, Atarashi R, Houtani T, Torchia M, Sakaguchi S, DeArmond SJ, Prusiner SB, Katamine S (1999) A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination. Lab Invest 79:689–697 CASPubMed Google Scholar
Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, Aguzzi A, Weissmann C (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J 20:694–702 CASPubMed Google Scholar
Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528–531 CASPubMed Google Scholar
Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y, Mastrangelo P, Wang K, Smit AF, Katamine S, Carlson GA, Cohen FE, Prusiner SB, Melton DW, Tremblay P, Hood LE, Westaway D (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 292:797–817 CASPubMed Google Scholar
Anderson L, Rossi D, Linehan J, Brandner S, Weissmann C (2004) Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment. Proc Natl Acad Sci USA 101:3644–3649 CASPubMed Google Scholar
Genoud N, Behrens A, Miele G, Robay D, Heppner FL, Freigang S, Aguzzi A (2004) Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions. Proc Natl Acad Sci USA 101:4198–4203 ArticleCASPubMed Google Scholar
Kuwahara C, Takeuchi A, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T (1999) Prions prevent neuronal cell-line death. Nature 400:225–226 ArticleCASPubMed Google Scholar
Kim BH, Lee HG, Choi JK, Kim JI, Choi EK, Carp RI, Kim YS (2004) The cellular prion protein (PrP (C)) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res 124:40–50 CASPubMed Google Scholar
Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA (1997) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146:104–112 ArticleCASPubMed Google Scholar
Brown DR, Nicholas RS, Canevari L (2002) Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67:211–224 ArticleCASPubMed Google Scholar
White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R (1999) Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 155:1723–1730 CASPubMed Google Scholar
Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, BrownDR, Sy MS (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76:565–572 ArticleCASPubMed Google Scholar
Klamt F, Dal-Pizzol F, Conte da Frota MJ, Walz R, Andrades ME, da Silva EG, Brentani RR, Izquierdo I, Fonseca Moreira JC (2001) Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 30:1137–1144 ArticleCASPubMed Google Scholar
Vassallo N, J Herms (2003) Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86:538–544 ArticleCASPubMed Google Scholar
Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344:1–5 ArticleCASPubMed Google Scholar
Wong BS, Pan T, Liu T, Li R, Gambetti P, Sy MS (2000) Differential contribution of superoxide dismutase activity by prion protein in vivo. Biochem Biophys Res Commun 273:136–139 ArticleCASPubMed Google Scholar
Hutter G, Heppner FL, Aguzzi A (2003) No superoxide dismutase activity of cellular prion protein in vivo. Biol Chem 384:1279–1285 ArticleCASPubMed Google Scholar
Sakudo A, Lee DC, Saeki K, Nakamura Y, Inoue K, Matsumoto Y, Itohara S, Onodera T (2003) Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem Biophys Res Commun 308:660–667 ArticleCASPubMed Google Scholar
Nakamura Y, Sakudo A, Saeki K, Kaneko T, Matsumoto Y, Toniolo A, Itohara S, Onodera T (2003) Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells. J Gen Virol 84:3495–3502 ArticleCASPubMed Google Scholar
Grossman A, Zeiler B, Sapirstein V (2003) Prion protein interactions with nucleic acid: possible models for prion disease and prion function. Neurochem Res 28:955–963 ArticleCASPubMed Google Scholar
Leblanc P, Baas D, Darlix JL (2004) Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. J Mol Biol 337:1035–1051 ArticleCASPubMed Google Scholar
LeBlanc A (1998) Unravelling the controversy of prion diseases. In: Wang SSAE (ed) Handbook of the aging brain. Academic, New York, pp 202–214
Yin X-M, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321–323 ArticleCASPubMed Google Scholar
Kurschner C, Morgan J (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid sustem. Brain Res Mol Brain Res 30:165–168 CASPubMed Google Scholar
Kurschner C, Morgan J (1996) Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 37:249–258 CASPubMed Google Scholar
Bounhar Y, Zhang Y, Goodyer C, LeBlanc A (2001) Prion protein protects against Bax-mediated cell death. J Biol Chem 276:39145–39149 ArticleCASPubMed Google Scholar
Medori R, Tritschler H, LeBlanc A, Villare F, Manetto V, Chen H, Xue R, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw J, Lugaresi E, Autilio-Gambetti L, Gambetti P (1992) Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326:444–449 CASPubMed Google Scholar
Nitrini R, Rosemberg S, Passos-Bueno MR, Lughetti P, Papadopoulos M, Carrilho PE, Caramelli P, Albrecht S, Zatz M, LeBlanc AC (1997) Familial Spongiform Encephalopathy with distinct clinico-pathological features associated with a novel prion protein gene mutation at codon 183. Ann Neurol 42:138–146 CASPubMed Google Scholar
Roucou X, Guo G, Zhang Y, Goodyer CG, LeBlanc AC (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278:40877–40881 ArticleCASPubMed Google Scholar
Deckwerth TL, Elliott JL, Knudson CM, Johnson Jr EM, Snider WD, Korsmeyer SJ (1996) BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401–411 ArticleCASPubMed Google Scholar
Diarra-Mehrpour M, Arrabal S, Jalil A, Pinson X, Gaudin C, Pietu G, Pitaval A, Ripoche H, Eloit M, Dormont D, Chouaib S (2004) Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res 64:719–727 CASPubMed Google Scholar
Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153–161 ArticleCASPubMed Google Scholar
Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, Kellermann O (2003) NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 100:13326–13331 CASPubMed Google Scholar
Grewal SS, York RD, Stork PJ (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9:544–553 ArticleCASPubMed Google Scholar
Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289:1925–1928 ArticleCASPubMed Google Scholar
Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuroprotective signals. EMBO J 21:3317–3326 ArticleCASPubMed Google Scholar
Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21:3307–3316 CASPubMed Google Scholar
Chen S, Mange A, Dong L, Lehmann S, Schachner M (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22:227–233 CASPubMed Google Scholar
Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, Brentani RR (2000) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 76:85–92 CASPubMed Google Scholar
Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863–5875 ArticleCASPubMed Google Scholar
Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209–1225 ArticleCASPubMed Google Scholar
Spielhaupter C, Schatzl HM (2001) PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 276:44604–44612 ArticleCASPubMed Google Scholar
Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS (2002) Intercellular transfer of the cellular prion protein. J Biol Chem 277:47671–47678 ArticleCASPubMed Google Scholar
Yin XM (2000) Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10:161–167 CASPubMed Google Scholar
Martinou JC, Green DR (2001) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63–67 ArticleCASPubMed Google Scholar
Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C (2004) Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol 164:1021–1032 ArticleCASPubMed Google Scholar
Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S (2003) Deletion of N-terminal residues 23–88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/Doppel-induced neurodegeneration. J Biol Chem 278:28944–28949 ArticleCASPubMed Google Scholar
Behrens A, Aguzzi A (2002) Small is not beautiful: antagonizing functions for the prion protein PrP (C) and its homologue Dpl. Trends Neurosci 25:150–154 ArticleCASPubMed Google Scholar
Wong BS, Liu T, Paisley D, Li R, Pan T, Chen SG, Perry G, Petersen RB, Smith MA, Melton DW, Gambetti P, Brown DR, Sy MS (2001) Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function. Mol Cell Neurosci 17:768–775 ArticleCASPubMed Google Scholar
Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, Rulicke T, Flechsig E, Cozzio A, von Mering C, Hangartner C, Aguzzi A, Weissmann C (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203–214 ArticleCASPubMed Google Scholar
Hoshino S, Inoue K, Yokoyama T, Kobayashi S, Asakura T, Teramoto A, Itohara S (2003) Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir Suppl 86:297–299 CASPubMed Google Scholar
Marciano PG, Brettschneider J, Manduchi E, Davis JE, Eastman S, Raghupathi R, Saatman KE, Speed TP, Stoeckert CJ Jr, Eberwine JH, McIntosh TK (2004) Neuron-specific mRNA complexity responses during hippocampal apoptosis after traumatic brain injury. J Neurosci 24:2866–2876 ArticleCASPubMed Google Scholar
Shyu WC, Kao MC, Chou WY, Hsu YD, Soong BW (2000) Heat shock modulates prion protein expression in human NT-2 cells. Neuroreport 11:771–774 CASPubMed Google Scholar
Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40:1679–1682 CASPubMed Google Scholar
Chacon MA, Barria MI, Lorca R, Huidobro-Toro JP, Inestrosa NC (2003) A human prion protein peptide (PrP (59–91)) protects against copper neurotoxicity. Mol Psychiatry 8:853–862:835 Google Scholar
Paitel E, Alves da Costa C, Vilette D, Grassi J, Checler F (2002) Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J Neurochem 83:1208–1214 ArticleCASPubMed Google Scholar
Paitel E, Fahraeus R, Checler F (2003) Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. J Biol Chem 278:10061–10066 ArticleCASPubMed Google Scholar
Paitel E, Sunyach C, Alves da Costa C, Bourdon JC, Vincent B, Checler F (2004) Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J Biol Chem 279:612–618 ArticleCASPubMed Google Scholar
Hegde RS, Voigt S, Lingappa VR (1998) Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol Cell 2:85–91 ArticleCASPubMed Google Scholar
Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827–834 ArticleCASPubMed Google Scholar
Ma J, Wollmann R, Lindquist S (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781–1785 ArticleCASPubMed Google Scholar
Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98:14955–14960 ArticleCASPubMed Google Scholar
Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 20:5383–5391 CASPubMed Google Scholar
Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, Fioriti L, Chiesa R, Harris DA (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278:21732–21743 CASPubMed Google Scholar
Heller U, Winklhofer KF, Heske J, Reintjes A, Tatzelt J (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem 278:36139–36147 ArticleCASPubMed Google Scholar
Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966–1968 ArticleCASPubMed Google Scholar
Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, Hardwick JM (1998) Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 95:554–559 ArticleCASPubMed Google Scholar
Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744–748 ArticleCASPubMed Google Scholar
Kitamoto T, Iizuka R, Tateishi J (1993) An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192:525–531 ArticleCASPubMed Google Scholar
Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514–1516 ArticleCASPubMed Google Scholar
Meier P, Genoud N, Prinz M, Maissen M, Rulicke T, Zurbriggen A, Raeber AJ, Aguzzi A (2003) Soluble dimeric prion protein binds PrP (Sc) in vivo and antagonizes prion disease. Cell 113:49–60 ArticleCASPubMed Google Scholar
Hegde R, Tremblay P, Groth D, DeArmond S, Prusiner S, Lingappa V (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822–826 ArticleCASPubMed Google Scholar
Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421 ArticleCASPubMed Google Scholar
Lorenz H, Windl O, Kretzschmar HA (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516 ArticleCASPubMed Google Scholar
Zanusso G, Petersen RB, Jin T, Jing Y, Kanoush R, Ferrari S, Gambetti P, Singh N (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274:23396–23404 ArticleCASPubMed Google Scholar
Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301–311 CASPubMed Google Scholar
Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871–874 ArticleCASPubMed Google Scholar